Owlet (OWLT) Return on Capital Employed (2021 - 2026)
Owlet's (OWLT) quarterly Return on Capital Employed came in at 29.12% in Q1 2026, up 14652.0% year-on-year from N/an in Q1 2025, and down 26.94% on a QoQ basis from 22.94% in Q4 2025.
Owlet (OWLT) Return on Capital Employed (2021 - 2026) Analysis & Trends
Owlet (OWLT) has 6 years of Return on Capital Employed data on file, last reported at 29.12% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 14652.0% year-over-year to 29.12% in Q1 2026; TTM through Mar 2026 was 29.12%, a 14652.0% increase from a year earlier, with the FY2025 full-year figure at 35.41%, up 15920.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 29.12%, down from 22.94% in the prior quarter.
- Over the last five years, Return on Capital Employed for OWLT reached as high as 1518.54% in Q4 2023 and fell as low as 3032.94% in Q4 2022.
- Historically, Return on Capital Employed has averaged 365.6% across 5 years, with a median of 222.12% in 2022.
- Across the five-year window, Return on Capital Employed tumbled 296412 bps in 2022 and jumped 455148 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 3032.94% in 2022, then jumped by 150 bps to 1518.54% in 2023, then slumped by 108 bps to 123.34% in 2024, then jumped by 81 bps to 22.94% in 2025, then declined by 27 bps to 29.12% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 29.12% in Q1 2026, 22.94% in Q4 2025, and 172.07% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Owlet | 147.80 Mn | 106.79 Mn | 12.24 Mn | -29.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.12% |
| Dec 31, 2025 | -22.94% |
| Sep 30, 2025 | -172.07% |
| Jun 30, 2025 | -360.02% |
| Mar 31, 2025 | -175.65% |
| Dec 31, 2024 | -123.34% |
| Sep 30, 2024 | -103.73% |
| Jun 30, 2024 | -699.21% |
| Mar 31, 2024 | -518.24% |
| Dec 31, 2023 | 1,518.54% |
| Sep 30, 2023 | -533.71% |
| Jun 30, 2023 | -455.70% |
| Mar 31, 2023 | -653.97% |
| Dec 31, 2022 | -3,032.94% |
| Sep 30, 2022 | -507.56% |
| Jun 30, 2022 | -222.12% |
| Mar 31, 2022 | -123.35% |
| Dec 31, 2021 | -68.82% |
| Sep 30, 2021 | -16.48% |
| Jun 30, 2021 | -4.55% |